Abstract:Mitral regurgitation (MR) is one of the most common valvular pathologies worldwide, contributing to the morbidity and mortality of several cardiovascular pathologies, including heart failure (HF). Novel transcatheter treatment for MR has given the opportunity for a safe and feasible alternative, to surgery, in order to repair the valve and improve patient outcomes. However, after the results of early transcatheter edge-to-edge repair (TEER) trials, it has become evident that subcategorizing the mitral regurgitation etiology and the left ventricular function, in patients due to undergo TEER, is of the essence, in order to predict responsiveness to treatment and select the most appropriate patient phenotype. Thus, a novel MR phenotype, atrial functional MR (AFMR), has been recently recognized as a distinct pathophysiological entity, where the etiology of the regurgitation is secondary to annular dilatation, in a diseased left atrium, with preserved left ventricular function. Recent studies have evaluated and compared the outcomes of TEER in AFMR with ventricular functional MR (VFMR), with the results favoring the AFMR. In specific, TEER in this patient substrate has better echocardiographic and long-term outcomes. Thus, our review will provide a comprehensive pathogenesis and mechanistic overview of AFMR, insights into the echocardiographic approach of such patients and pre-procedural planning, discuss the most recent clinical trials and their implications for future treatment directions, as well as highlight future frontiers of research in the setting of TEER and transcatheter mitral valve replacement (TMVR) in AFMR patients.

Transcatheter mitral regurgitation therapeutics: state-of-art 2018

Transcatheter Treatment of Mitral Regurgitation: Current Status and Future Prospects

Transcatheter Interventions for Mitral Regurgitation: Multimodality Imaging for Patient Selection and Procedural Guidance

Current status and future prospect of transcatheter mitral valve replacement

Update of Transcatheter Valve Treatment

Comparison of Different Transcatheter Interventions for Treatment of Mitral Regurgitation

Transcatheter aortic valve replacement in 2016

Evolving capabilities of computed tomography imaging for transcatheter valvular heart interventions – new opportunities for precision medicine

The current situation of transcatheter aortic valve replacement in China 2017

Emerging Transcatheter Therapies for Valvular Heart Disease: Focus on Mitral and Tricuspid Valve Procedures

Ten Future Challenges in the Field of Transcatheter Mitral Valve Edge-to-Edge Repair

First-in-Human Study of the Novel Transcatheter Mitral Valve Repair System for Mitral Regurgitation.

Transcatheter tricuspid valve interventions: Current status and future perspectives

Transcatheter interventional therapy for heart valve disease: applications and challenges

A deep dive into the percutaneous mitral valve data

Engineering challenges and the future prospects of transcatheter mitral valve replacement technologies: a comprehensive review of case studies

New Therapeutic Advances in the Management of Tricuspid Valve Regurgitation

Contemporary diagnosis and management of severe tricuspid regurgitation

Current Status of Catheter-based Mitral Valve Replacement

New understanding and application of the mechanism of mitral regurgitation

From Diagnosis to Current Interventional Therapies